Literature DB >> 16650327

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan.

L Qin1, H Watanabe, H Yoshimine, H Guio, K Watanabe, K Kawakami, A Iwagaki, H Nagai, H Goto, T Kuriyama, Y Fukuchi, T Matsushima, S Kudoh, K Shimada, K Matsumoto, T Nagatake, T Mizota, K Oishi.   

Abstract

A nationwide study was undertaken to determine the susceptibility to penicillin and serotypes of Streptococcus pneumoniae in Japan. S. pneumoniae was isolated from 114 adult patients with community-acquired pneumonia over 22 months at 20 hospitals and medical centres in different regions in Japan. All but five isolates were from sputum. Forty-eight isolates (42.1%) were susceptible, 40 (35.1%) showed intermediate resistance (MIC, 0.12-1.0 microg/ml) and 26 (22.8%) were resistant (MIC, >or=2.0 microg/ml) to penicillin G. All isolates were susceptible to ceftriaxone (breakpoint 1 microg/ml), imipenem (4 microg/ml) and vancomycin (4 microg/ml). Most were resistant to erythromycin, clarithromycin and azithromycin; only two were resistant to levofloxacin. Differences were found in the distribution of serotypes among isolates showing susceptibility to penicillin (predominant types 3, 6B, and 19F), intermediate resistance (6B, 14, 19F, and 23F) and full resistance (19F and 23F). PFGE typing showed that 14 of the 25 strains of serotype 19F had a single DNA profile, pattern A, a pattern closely similar to that of the Taiwan multidrug-resistant 19F clone. Twelve pattern A strains were not susceptible to penicillin but carried the macrolide resistance gene mef(A). The DNA profiles of the 15 strains of 23F were also heterogeneous but six were highly similar (pattern b) yet distinct from the Spanish multidrug-resistant 23F clone although possibly related to the Taiwan multidrug-resistant 23F clone. The pattern b strains were not susceptible to penicillin and also harboured either mef(A) or erm(B). Our results indicate that multidrug-resistant pneumococci are spreading rapidly in Japan. Efforts to prevent the spread of the pandemic multidrug-resistant serotypes should be intensified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650327      PMCID: PMC2870516          DOI: 10.1017/S0950268806006303

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-04-04

2.  Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.

Authors:  Javier Aspa; Olga Rajas; Felipe Rodríguez de Castro; José Blanquer; Rafael Zalacain; Asunción Fenoll; Rosa de Celis; Antonio Vargas; Francisco Rodríguez Salvanés; Pedro Pablo España; Jordi Rello; Antoni Torres
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

3.  Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).

Authors:  J Liñares; R Pallares; T Alonso; J L Perez; J Ayats; F Gudiol; P F Viladrich; R Martin
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

4.  Rapid increase of pneumococcal resistance to beta-lactam and other antibiotics in isolates from the respiratory tract (Nagasaki, Japan: 1975-1994).

Authors:  N Rikitomi; P S Sow; K Watanabe; D S Nunez; G Martinez; T Nagatake
Journal:  Microbiol Immunol       Date:  1996       Impact factor: 1.955

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 6.  Antimicrobial resistance in Streptococcus pneumoniae: an overview.

Authors:  P C Appelbaum
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

7.  Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes.

Authors:  Kwan Soo Ko; Jae-Hoon Song
Journal:  J Infect Dis       Date:  2004-07-13       Impact factor: 5.226

8.  Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.

Authors:  Stephanie J Schrag; Lesley McGee; Cynthia G Whitney; Bernard Beall; Allen S Craig; Miriam E Choate; James H Jorgensen; Richard R Facklam; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 9.  Pneumococcal vaccines: an update on current strategies.

Authors:  D Bogaert; P W M Hermans; P V Adrian; H C Rümke; R de Groot
Journal:  Vaccine       Date:  2004-06-02       Impact factor: 3.641

10.  Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan.

Authors:  T Ishida; T Hashimoto; M Arita; I Ito; M Osawa
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

View more
  4 in total

Review 1.  Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.

Authors:  Jonathan Ilowite; Peter Spiegler; Heather Kessler
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  Antimicrobial susceptibility and genetic characteristics of Streptococcus pneumoniae isolates indicating possible nosocomial transmission routes in a community hospital in Japan.

Authors:  Liang Qin; Hironori Masaki; Kiwao Watanabe; Akitsugu Furumoto; Hiroshi Watanabe
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

3.  Rutin Inhibits Streptococcus suis Biofilm Formation by Affecting CPS Biosynthesis.

Authors:  Shuai Wang; Chang Wang; Lingfei Gao; Hua Cai; Yonghui Zhou; Yanbei Yang; Changgeng Xu; Wenya Ding; Jianqing Chen; Ishfaq Muhammad; Xueying Chen; Xinmiao He; Di Liu; Yanhua Li
Journal:  Front Pharmacol       Date:  2017-06-16       Impact factor: 5.810

Review 4.  Community-Acquired Pneumonia in the Asia-Pacific Region.

Authors:  Jae-Hoon Song; Kyungmin Huh; Doo Ryeon Chung
Journal:  Semin Respir Crit Care Med       Date:  2016-12-13       Impact factor: 3.119

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.